Volume 4 Number 5
Editorial
EAPCI column
94
“Stent 4 Life” Targeting PCI at all who will benefit the most
A joint project between EAPCI, Euro-PCR, EUCOMED and the ESC Working Group on Acute Cardiac CareEuroInterv.2009;4:555-557
Clinical research
95
Keynote Address – EuroPCR 2008, Barcelona, May 14th, 2008
Transcatheter aortic valve implantation: state of the artEuroInterv.2009;4 558-565
96
First-in-man (FIM) study of the Stentys™ bifurcation stent – 30 days resultsVerheye S, Grube E, Ramcharitar S, Schofer J, Witzenbichler B, Kovac J, Hauptmann K, Agostoni P, Wiemer M, Lefèvre T, Serruys PW, Geuns R
EuroInterv.2009;4:566-571
97
TAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesionsGrube E, Dawkins K, Guagliumi G, Banning A, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Joshi A, Mascioli S
EuroInterv.2009;4 572-577
98
Interventional treatment in diabetics in the era of drug-eluting stents and compliance to the ESC guidelines: lessons learned from the Euro Heart Survey ProgrammeEuroInterv.2009;4 578-587
99
Impact of atherosclerotic disease progression on mid-term clinical outcome in diabetic patients in the drug-eluting stent eraEuroInterv.2009;4 588-592
100
Incidence of stent thrombosis in patients with drug eluting stents and short-term dual antiplatelet therapySteinwender C, Hartenthaler B, Lambert T, Kypta A, Kammler J, Hönig S, Hofmann R, Kerschner K, Leisch F
EuroInterv.2009;4 593-599
101
Percutaneous coronary intervention for chronic total occlusions: the role of side-branch obstructionEuroInterv.2009;4 600-606
102
Computed Tomography in Total coronary Occlusions (CTTO Registry): radiation exposure and predictors of successful percutaneous interventionGarcía-García H, Van Mieghem H, Gonzalo N, Meijboom W, Weustink A, Onuma Y, Mollet N, Schultz J, Meliga E, van der Ent M, Sianos G, Goedhart D, den Boer A, de Feyter P, Serruys PW
EuroInterv.2009;4 607-616
103
Primary percutaneous coronary intervention for acute myocardial infarction secondary to acute left main coronary occlusion in an institution without on-site cardiothoracic surgical supportEuroInterv.2009;4 617-619
104
Cheatham Platinum (CP) and Palmaz stents for cardiac and vascular lesions treatment in patients with congenital heart diseaseEuroInterv.2009;4:620-625
105
In vivo characterisation of coronary plaques with conventional grey-scale intravascular ultrasound: correlation with optical coherence tomographyEuroInterv.2009;4:626-632
106
Re-examining minimal luminal diameter relocation and quantitative coronary angiography – intravascular ultrasound correlations in stented saphenous vein grafts: methodological insights from the randomised RRISC trialSemeraro O, Agostoni P, Verheye S, van Langenhove G, Van den Heuvel P, Convens C, van den Branden F, Bruining N, Vermeersch P
EuroInterv.2009;4 633-640
107
Prevalence and characteristics of major and minor coronary artery anomalies in an adult population assessed by computed tomography coronary angiographyEuroInterv.2009;4 641-647
108
Novel method for real-time hybrid cardiac CT and coronary angiography image registration: visualising beyond luminology, proof-of-conceptEuroInterv.2009;4 648-653
109
Plaque and shear stress distribution in human coronary bifurcations: a multislice computed tomography studyvan der Giessen A, Wentzel J, Meijboom W, Mollet N, van der Steen A, van de Vosse F, de Feyter P, Gijsen F
EuroInterv.2009;4 654-661
110
Incidence, patient characteristics and predictors of aborted myocardial infarction in patients undergoing primary PCI: prospective study comparing pre- and in-hospital abciximab pretreatmentHassan A, Jukema W, van der Laarse A, Hasan-Ali H, Wolterbeek R, van der Kley F, Spano F, Atsma D, Schalijv M
EuroInterv.2009;4:662-668
Expert review
111
The use of self-expanding stents in coronary bifurcations and beyond: a paradigm revisitedEuroInterv.2009;4:669-675
Special feature
Volume 4 Number 5 has been released thanks to the support of the following partners:
- Abbott Vascular Devices
- Cordis, a Johnson & Johnson company
- Hexacath
- Medtronic
- Terumo



